Pan-cancer analyses of TCGA tumors reveal a higher abundance of total and CD8+ T cells as well as increased immune cytotoxicity in MLL3- or MLL4-mutated tumors compared to tumors devoid of changes in the respective gene (Fig. 2q, r, and Supplementary Fig. 2n, o). The gene discussed is KMT2C; the disease is cancer.